… progression of prostate cancer from diagnosis to death is proposed. The model includes a
representation of both the natural and treated history of the disease … of disease progression. …

… disease, however, must be treated with pharmacological inhibitors of androgen receptor (AR)
activity, since disease progression … to PCa initiation and progression to incurable disease. …

… genes involved in progression of prostate cancer, molecular markers may offer additional
hallmarks of cancer progression and our failure to cure this all-too-common cancer. So far, …

… the phenomenon of tumour progression. The unusually low proportion of metastatic prostate
cancers is readily explained by the large proportion of small-volume tumours in this organ. …

… of prostate cancer evolution during progression is required. In … prostate cancer progression,
but challenge the prevailing view by proposing a new model of prostate cancer progression, …

… prognostic models are based on pre-treatment prostate specific antigen (PSA) … disease
progression. Hence, we sought to develop a molecular panel for prostate cancer progression by …

… in prostate cancer pathogenesis in a biological and clinical context and demonstrates how
integrated analysis of high-throughput data augments our understanding of prostate cancer. …

… from other disease processes decreases, prostate cancer is … disease with digital rectal
examination, serum prostate … confined prostate cancer are found to have extraprostatic disease. …

… During disease progression from primary towards metastatic prostate cancer (PCa), and in
… (TME) evolves in parallel with the cancer clones, altering extracellular matrix composition (…

Purpose Following treatment for localized prostate cancer, men are monitored with serial
prostate-specific antigen (PSA) measurements. Refining the predictive value of post-treatment …